Pacira BioSciences Inc.
PCRX | NASDAQ
$24.77
+$0.66 (+2.74%)
Sep 22, 2026, 11:33 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 192.4M | 177.38M | 196.87M | 179.52M | 181.1M | 168.92M | 187.25M | 168.57M | 178.02M | 167.12M | 181.24M | 163.93M | 169.47M | 160.34M | 171.96M | 167.47M | 169.41M | 157.99M | 159.19M | 127.72M | 135.59M | 119.03M |
Cost of Revenue | 44.16M | 36.41M | 40.3M | 34.28M | 40.87M | 34.31M | 39.89M | 38.86M | 44.26M | 47.42M | 47.69M | 39.75M | 48.21M | 49.02M | 61.92M | 50.68M | 50.63M | 36.07M | 39.01M | 34.65M | 35.25M | 31.35M |
Gross Profit | 148.24M | 140.96M | 156.57M | 145.24M | 140.23M | 134.62M | 147.37M | 129.71M | 133.76M | 119.7M | 133.55M | 124.18M | 121.26M | 111.32M | 110.04M | 116.79M | 118.78M | 121.92M | 120.19M | 93.07M | 100.34M | 87.68M |
Operating Income | 4.27M | 4.63M | 3.19M | 6.36M | 8.5M | 1.99M | 24.7M | -139.53M | 28.24M | 13.21M | 33.17M | 17.72M | 39.88M | -3.09M | -9.89M | 21.29M | 31.24M | 17.39M | 4.21M | 31.43M | 34.84M | 19.44M |
Interest Income | 1.94M | 1.93M | 2.3M | 8.53M | 5.01M | 6.9M | 5.56M | 5.48M | 4.75M | 3.9M | 3.43M | 2.77M | 2.11M | 3.14M | 2.79M | 1.23M | 252K | 271K | 79K | 177K | 224K | 415K |
Pretax Income | 2.56M | 5M | 571K | 9.52M | -1.93M | 8.71M | 25.53M | -138.86M | 36.58M | 13.64M | 33.72M | 16.6M | 37.85M | -26.47M | -18.07M | 2.07M | 22.01M | 7.29M | -6.2M | 24.23M | 25.65M | 12.72M |
Net Income | 4.65M | 2.92M | 1.64M | 5.43M | -4.85M | 4.81M | 16.04M | -143.47M | 18.89M | 8.98M | 24.87M | 10.86M | 25.76M | -19.54M | -10.1M | -693K | 19.88M | 6.83M | -5.13M | 17.66M | 19.08M | 10.37M |
Selling & General & Admin | 91.81M | 93.94M | 101.61M | 91.8M | 88.58M | 86.78M | 79.61M | 74.33M | 68.13M | 72.03M | 65.8M | 67.95M | 64.85M | 70.84M | 63.97M | 61.28M | 65M | 64.26M | 51.2M | 47.86M | 50.81M | 48.52M |
Research & Development | 30.24M | 28.07M | 37.45M | 25.97M | 28.2M | 25.34M | 23.9M | 19.1M | 20.34M | 18.24M | 19.46M | 20.83M | 18.82M | 17.14M | 17.51M | 19.41M | 26.28M | 21.61M | 15.51M | 11.58M | 12.57M | 15.88M |
Other Expenses | 21.92M | 14.32M | 14.32M | 21.11M | 14.96M | 20.51M | 19.15M | 175.8M | 17.06M | 16.23M | 15.12M | 17.68M | -2.29M | 26.43M | 38.46M | 14.81M | -3.74M | 18.66M | 49.26M | 2.2M | 2.11M | 3.84M |
Operating Expenses | 143.97M | 136.34M | 153.38M | 138.88M | 131.73M | 132.63M | 122.66M | 269.24M | 105.52M | 106.49M | 100.38M | 106.46M | 81.38M | 114.41M | 119.93M | 95.5M | 87.55M | 104.52M | 115.98M | 61.64M | 65.5M | 68.24M |
Interest Expense | 3.62M | 3.18M | 3.37M | 3.65M | 4.7M | 4.58M | 3.83M | 4.69M | 3.12M | 3.32M | 3.39M | 3.46M | 3.87M | 9.59M | 11.04M | 9.86M | 8.83M | 10.25M | 10.42M | 7.33M | 7.02M | 6.97M |
Selling & Marketing Expenses | n/a | 58.17M | 61.61M | 58.47M | 50.96M | 55.57M | 50.34M | 43.19M | 39.05M | 39.44M | 35.74M | 38.26M | 37.46M | 41.58M | 36M | 33.71M | 36.85M | 38.44M | 29.36M | 26.3M | 28.26M | 27.1M |
Cost & Expenses | 188.13M | 172.75M | 193.68M | 173.15M | 172.6M | 166.93M | 162.55M | 308.1M | 149.78M | 153.91M | 148.08M | 146.21M | 129.59M | 163.43M | 181.85M | 146.18M | 138.18M | 140.6M | 154.98M | 96.29M | 100.75M | 99.59M |
Income Tax Expense | -2.1M | 2.08M | -1.07M | 4.09M | 2.92M | 3.89M | 9.49M | 4.61M | 17.7M | 4.66M | 8.85M | 5.74M | 12.09M | -6.94M | -7.97M | 2.76M | 2.13M | 466K | -1.07M | 6.57M | 6.57M | 2.36M |
Shares Outstanding (Basic) | 39.46M | 40.46M | 42.49M | 44.04M | 45.46M | 46.28M | 46.17M | 46.13M | 46.17M | 46.5M | 46.44M | 46.42M | 46.09M | 45.95M | 45.88M | 45.83M | 45.5M | 44.87M | 44.59M | 44.48M | 44.15M | 43.83M |
Shares Outstanding (Diluted) | 40.3M | 40.91M | 42.98M | 44.46M | 45.46M | 46.53M | 49.04M | 46.13M | 50.54M | 52.19M | 52.06M | 52.07M | 52.05M | 45.95M | 45.88M | 45.83M | 52.48M | 46.44M | 44.59M | 45.46M | 45.59M | 45.97M |
EPS (Basic) | 0.12 | 0.07 | 0.04 | 0.12 | -0.11 | 0.10 | 0.35 | -3.11 | 0.41 | 0.19 | 0.54 | 0.23 | 0.56 | -0.43 | -0.22 | -0.02 | 0.44 | 0.15 | -0.12 | 0.40 | 0.43 | 0.24 |
EPS (Diluted) | 0.12 | 0.07 | 0.04 | 0.12 | -0.11 | 0.10 | 0.34 | -3.11 | 0.39 | 0.19 | 0.48 | 0.23 | 0.51 | -0.43 | -0.22 | -0.02 | 0.40 | 0.15 | -0.12 | 0.39 | 0.42 | 0.23 |
EBITDA | 25.6M | 29.51M | 25.29M | 34.37M | 29.24M | 33.61M | 50.6M | -114.75M | 58.57M | 34.7M | 54.91M | 37.82M | 60.08M | 1.78M | 21.94M | 31.22M | 50.83M | 36.39M | 16.52M | 36.63M | 36.91M | 23.9M |
EBIT | 4.3M | 8.18M | 3.94M | 13.18M | 1.92M | 12.44M | 29.36M | -135.01M | 39.71M | 16.28M | 36.42M | 19.38M | 41.03M | -17.82M | -8.47M | 11.02M | 29.97M | 16.36M | 3.45M | 30.9M | 32.01M | 19.04M |
Depreciation & Amortization | 21.3M | 21.33M | 21.34M | 21.19M | 27.32M | 21.17M | 21.24M | 20.25M | 18.86M | 18.43M | 18.49M | 18.43M | 19.05M | 19.6M | 30.41M | 20.2M | 20.86M | 20.03M | 13.07M | 5.73M | 4.9M | 4.85M |
Add to Watchlist
Select watchlists to add or remove PCRX